Anthropic published a detailed account on August 14, 2026 of how the text watermark in future Claude models works, identifying it as a version of the SynthID-Text technique Google DeepMind published ...

Billy Strings is still coming to terms with his mother’s death last June. The singer and guitarist takes one mere stop in that journey with his new album, So Much for Goodbyes. Due Aug. 28, the album ...

Physicists may have uncovered a surprising new clue that string theory—the idea that the universe is built from unimaginably tiny vibrating strings—could be more than just a mathematical fantasy.

Billy Strings, a two-time Grammy Award winner, from Ionia, confirmed on social media on Sunday, April 19, that he has broken his leg. Strings shared an X-ray on Facebook and Instagram of his leg ...

On Wednesday, the International Renewable Energy Agency (IRENA) released its numbers on what was built in 2025. And much as we saw in the US, solar power is the primary driver of change. The numbers ...

Billy Strings is coming back to Denver. The bluegrass virtuoso just announced the fall leg of his tour, which kicks off in April in St. Augustine, Florida. And lucky for us, the fall portion will ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

The Northwest’s only commercial nuclear power plant, the Columbia Generating Station, was manually shut down early Thursday morning due to a mechanical problem. Energy Northwest workers shut the plant ...

Before he became one of the biggest stars in bluegrass and country music, Billy Strings grew up in Muir, a small community located between Lansing and Grand Rapids. The Grammy Award-winning artist is ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...